Large-scale testing (Phase 3)Study completedNCT01981954
What this trial is testing
A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)
Who this might be right for
Neurogenic Detrusor OveractivityPediatric
Astellas Pharma Europe B.V. 23